Scienture Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	0.15	0.14	1.36	0.3
Revenue Growth (YoY)	-84.76%	-89.98%	354.61%	-
Cost of Revenue	0.14	0.13	1.31	-
Gross Profit	0.01	0.01	0.05	0.3
Selling, General & Admin	9.97	12.47	4.45	0.88
Research & Development	2.81	2.24	-	3.06
Operating Expenses	12.79	14.71	4.45	3.94
Operating Income	-12.78	-14.7	-4.4	-3.64
Interest Expense	-1.91	-1.34	-1.14	-0.08
Interest & Investment Income	0.1	0.14	0	-
Other Non Operating Income (Expenses)	1.98	-0	-0.15	0.01
EBT Excluding Unusual Items	-12.61	-15.9	-5.68	-3.71
Gain (Loss) on Sale of Investments	-2.5	-2.5	-	-
Gain (Loss) on Sale of Assets	-	-0.37	-2.8	-
Pretax Income	-15.21	-18.78	-8.48	-3.71
Income Tax Expense	-0.53	-0.53	-	-
Earnings From Continuing Operations	-14.68	-18.24	-8.48	-3.71
Earnings From Discontinued Operations	-0.57	27.31	-9.36	-
Net Income	-15.24	9.07	-17.84	-3.71
Net Income to Common	-15.24	9.07	-17.84	-3.71
Shares Outstanding (Basic)	5	3	1	5
Shares Outstanding (Diluted)	5	3	1	5
Shares Change (YoY)	427.86%	341.76%	-84.72%	-
EPS (Basic)	-2.79	2.69	-23.35	-0.74
EPS (Diluted)	-2.80	2.68	-23.35	-0.74
Free Cash Flow	-7.04	-14.28	-2.23	-3.35
Free Cash Flow Per Share	-1.29	-4.23	-2.91	-0.67
Gross Margin	4.55%	4.40%	3.60%	100.00%
Operating Margin	-8699.30%	-10758.70%	-322.36%	-1213.87%
Profit Margin	-10377.22%	6634.66%	-1308.34%	-1236.13%
Free Cash Flow Margin	-4795.08%	-10448.57%	-163.16%	-1117.56%
EBITDA	-12.78	-14.7	-3.56	-
EBITDA Margin	-	-	-261.20%	-
D&A For EBITDA	0	0	0.83	-
EBIT	-12.78	-14.7	-4.4	-3.64

Updated Nov 6, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q